These CD4+ T cells facilitate the maturation of DCs through interactions involving CD40-CD40L and MHC II/epitope-TCR, which allows for the cross-presentation of tumor antigens to CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.